Evidence-based smoking cessation treatment: a comparison by healthcare system

• Published in: BMC health services research Vol. 21; no. 1; p. 33
• Main Authors: Lewis, Jennifer A, Senft, Nicole, Chen, Heidi, Weaver, Kathryn E, Spalluto, Lucy B, Sandler, Kim L, Horn, Leora, Massion, Pierre P, Dittus, Robert S, Roumie, Christianne L, Tindle, Hilary A
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 07-01-2021; BioMed Central; BMC
• Subjects: Counseling; Cross-Sectional Studies; Delivery of Health Care; Electronic health records; Evaluation; Evidence-Based Medicine; FDA approval; Female; Guideline Adherence; Gynecology; Health Personnel; Health services; Hematology; Humans; Internal medicine; Lung cancer; Lung diseases; Medical referrals; Medical screening; Methods; Oncology; Patients; Physicians; Practice guidelines (Medicine); Pulmonology; Questionnaires; Regression analysis; Smoking Cessation; Smoking cessation programs; Tobacco; Variables; United States; United States > US
• ISSN: 1472-6963; 1472-6963
• DOI: 10.1186/s12913-020-06016-5

A systems-level approach to smoking cessation treatment may optimize healthcare provider adherence to guidelines. Institutions such as the Veterans Health Administration (VHA) are unique in their systematic approach, but comparisons of provider behavior in different healthcare systems are limited.
We surveyed general medicine providers and specialists in a large academic health center (AHC) and its affiliated VHA in the Mid-South in 2017 to determine the cross-sectional association of healthcare system in which the provider practiced (exposure: AHC versus VHA) with self-reported provision of evidence-based smoking cessation treatment (delivery of counseling plus smoking cessation medication or referral) at least once in the past 12 months (composite outcome). Multivariable logistic regression with adjustment for specialty was performed in 2017-2019.
Of 625 healthcare providers surveyed, 407 (65%) responded, and 366 (59%) were analyzed. Most respondents practiced at the AHC (273[75%] vs VHA 93[25%]) and were general internists (215[59%]); pulmonologists (39[11%]); hematologists/oncologists (69[19%]); and gynecologists (43[12%]). Most respondents (328[90%]) reported the primary outcome. The adjusted odds of evidence-based smoking cessation treatment were higher among VHA vs. AHC healthcare providers (aOR = 4.3; 95% CI 1.3-14.4; p = .02). Health systems differed by provision of individual treatment components, including smoking cessation medication use (98% VHA vs. 90% AHC, p = 0.02) and referral to smoking cessation services (91% VHA vs. 65% AHC p = 0.001).
VHA healthcare providers were significantly more likely to provide evidence-based smoking cessation treatment compared to AHC healthcare providers. Healthcare systems' prioritization of and investment in smoking cessation treatment is critical to improving providers' adherence to guidelines.